TOT BIOPHARM International Company Limited (1875.HK)

HKD 1.65

(0.0%)

Operating Income Summary of TOT BIOPHARM International Company Limited

TOT BIOPHARM International Company Limited's latest annual operating income in 2023 was -33.06 Million CNY , up 15.4% from previous year.
TOT BIOPHARM International Company Limited's latest quarterly operating income in 2024 Q2 was 33.25 Million CNY , down 0.0% from previous quarter.
TOT BIOPHARM International Company Limited reported an annual operating income of -39.07 Million CNY in 2022, up 84.95% from previous year.
TOT BIOPHARM International Company Limited reported an annual operating income of -259.7 Million CNY in 2021, up 10.04% from previous year.
TOT BIOPHARM International Company Limited reported a quarterly operating income of -33.06 Million CNY for 2023 FY, up 15.4% from previous quarter.
TOT BIOPHARM International Company Limited reported a quarterly operating income of -18.48 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of TOT BIOPHARM International Company Limited (2023 - 2017)

Historical Annual Operating Income of TOT BIOPHARM International Company Limited (2023 - 2017)

Year	Operating Income	Operating Income Growth
2023	-33.06 Million CNY	15.4%
2022	-39.07 Million CNY	84.95%
2021	-259.7 Million CNY	10.04%
2020	-288.67 Million CNY	-6.33%
2019	-271.49 Million CNY	-14.47%
2018	-237.17 Million CNY	-123.82%
2017	-105.96 Million CNY	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	33.25 Million CNY	0.0%
2023 FY	-33.06 Million CNY	15.4%
2023 Q4	-18.48 Million CNY	0.0%
2023 Q2	-14.57 Million CNY	0.0%
2022 FY	-39.07 Million CNY	84.95%
2022 Q4	-31.98 Million CNY	0.0%
2022 Q2	-6.94 Million CNY	0.0%
2021 Q2	-115.44 Million CNY	0.0%
2021 Q4	-140.01 Million CNY	0.0%
2021 FY	-259.7 Million CNY	10.04%
2020 Q4	-163.06 Million CNY	0.0%
2020 FY	-288.67 Million CNY	-6.33%
2020 Q2	-128.36 Million CNY	0.0%
2019 Q2	-110.97 Million CNY	0.0%
2019 Q4	-160.52 Million CNY	0.0%
2019 FY	-271.49 Million CNY	-14.47%
2018 Q2	-59.15 Million CNY	0.0%
2018 FY	-237.17 Million CNY	-123.82%
2018 Q1	-59.15 Million CNY	0.0%
2018 Q4	-67.87 Million CNY	0.0%
2017 Q2	-26.58 Million CNY	0.0%
2017 Q4	-59.15 Million CNY	0.0%
2017 Q1	-26.58 Million CNY	0.0%
2017 FY	-105.96 Million CNY	0.0%
2016 Q4	-26.58 Million CNY	0.0%

Peer Operating Income Comparison of TOT BIOPHARM International Company Limited

Name	Operating Income	Operating Income Difference
Uni-Bio Science Group Limited	67.76 Million HKD	148.784%
CK Life Sciences Int'l., (Holdings) Inc.	897.95 Million HKD	103.682%